No black box warning on record for Dapagliflozin And Saxagliptin
As of the latest FDA labeling reviewed, Dapagliflozin And Saxagliptin (DAPAGLIFLOZIN AND SAXAGLIPTIN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Dapagliflozin And Saxagliptin medicine page for the complete safety profile.